Acceptability and continuation of use of the subdermal contraceptive implant among adolescents and young women in Argentina: a retrospective cohort study

Abstract A new public policy was instituted in Argentina for free distribution of subdermal contraceptive implants to women aged 15–24 years old in the public healthcare system. The objective of this study is to determine the extent to which this population adhered to the implant, as well as predictors of continuation. The retrospective cohort study was based on a telephone survey of a random sample of 1101 Ministry of Health-registered implant users concerning the continuation of use, satisfaction with the method and side-effects, and reasons for removal. Descriptive statistics and multivariate regression analysis were used to explore the association between adherence and having received contraceptive counselling, satisfaction, and side effects. We found high levels of adherence (87%) and satisfaction (94%). Common reported side effects were amenorrhoea or infrequent bleeding, perceived weight gain, increased menstrual bleeding and headaches. Multivariate regression analysis indicates that, among adolescents, having received contraceptive counselling increased comfort, while frequent bleeding at six months hindered trust. Participants who had a history of a prior delivery or who had themselves primarily chosen the method were less likely to request the removal of the implant. Our results support the public policy of free implant distribution in the public health sector. This is a sustainable public policy that contributes to equity and access to effective contraception. It is appropriate for adolescents and young women and will also reduce unintended pregnancies. Our results suggest that counselling patients is key prior to insertion of the implant, as it improves acceptability and continuation.

[1]  B. Darney,et al.  Contraceptive Receipt Among First-Trimester Abortion Clients and Postpartum Women in Urban Mexico. , 2020, International perspectives on sexual and reproductive health.

[2]  J. Bongaarts,et al.  United Nations Department of Economic and Social Affairs, Population Division World Family Planning 2020: Highlights, United Nations Publications, 2020. 46 p. , 2020 .

[3]  A. Barros,et al.  Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries , 2019, The Lancet. Global health.

[4]  L. Bahamondes,et al.  The use of long-acting reversible contraceptives in Latin America and the Caribbean: current landscape and recommendations , 2018, Human reproduction open.

[5]  David A. Klein,et al.  Long‐acting reversible contraception in adolescents: a systematic review and meta‐analysis , 2017, American journal of obstetrics and gynecology.

[6]  Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices. , 2017, Obstetrics and gynecology.

[7]  J. Peipert,et al.  Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC). , 2016, American journal of obstetrics and gynecology.

[8]  Maria I. Rodriguez,et al.  Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico , 2016, Maternal and Child Health Journal.

[9]  A. Rocha,et al.  Non-hormonal and hormonal intrauterine contraception: survey of patients’ perceptions in four Latin American countries , 2016, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[10]  Moazzam Ali,et al.  A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls. , 2015, Human reproduction.

[11]  J. Peipert,et al.  The Contraceptive CHOICE Project Round Up: What We Did and What We Learned , 2014, Clinical obstetrics and gynecology.

[12]  T. Palermo,et al.  IUDs as EC? Limited awareness and high reported acceptability: evidence from Argentina. , 2014, Contraception.

[13]  M. H. Sousa,et al.  Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic. , 2014, Human reproduction.

[14]  S. Ricketts,et al.  Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women. , 2014, Perspectives on sexual and reproductive health.

[15]  L. Bahamondes,et al.  A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. , 2014, Human reproduction.

[16]  M. Power,et al.  Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education. , 2014, Contraception.

[17]  Juan Pablo Real,et al.  Perfil de consumo de anticonceptivos orales en la ciudad de Córdoba, Argentina , 2014 .

[18]  S. Wilkes Long-acting reversible contraception. , 2013, The British journal of general practice : the journal of the Royal College of General Practitioners.

[19]  R. Pittrof,et al.  Counselling styles and their effect on subdermal contraceptive implant continuation rates , 2011, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[20]  J. Lucke,et al.  Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia. , 2009, Contraception.

[21]  A. Davidson,et al.  Determinants of early implant discontinuation among low-income women. , 1996, Family planning perspectives.

[22]  D. Bromham,et al.  Impact of patient counseling on acceptance of the levonorgestrel implant contraceptive in the United Kingdom. , 1996, Clinical therapeutics.

[23]  J. Trussell Contraceptive efficacy. , 1995, Archives of dermatology.

[24]  C. Dolea,et al.  World Health Organization , 1949, International Organization.